In this era of precision medicine, our understanding and knowledge of the molecular landscape associated with lung cancer pathogenesis continues to evolve. This information is being increasingly exploited to treat advanced stage lung cancer patients with tailored, targeted therapy. During the management of these patients, minimally invasive procedures to obtain samples for tissue diagnoses are desirable. Cytologic fine-needle aspirates are often utilized for this purpose and are important not only for rendering diagnoses to subtype patients’ lung cancers, but also for ascertaining molecular diagnostic information for treatment purposes. Thus, cytologic fine-needle aspirates must be utilized and triaged judiciously to achieve both objectives. In this review, strategies in utilizing fine-needle aspirates will be discussed in the context of our current understanding of the clinically actionable molecular aberrations underlying non-small cell lung cancer and the molecular assays applied to these samples in order to obtain treatment-relevant molecular diagnostic information.
Citations
Citations to this article as recorded by
The American Cancer Society National Lung Cancer Roundtable strategic plan: Methods for improving turnaround time of comprehensive biomarker testing in non–small cell lung cancer Sinchita Roy‐Chowdhuri, Haresh Mani, Adam H. Fox, Anne Tsao, Lynette M. Sholl, Farhood Farjah, Bruce E. Johnson, Raymond U. Osarogiagbon, M. Patricia Rivera, Gerard A. Silvestri, Robert A. Smith, Ignacio I. Wistuba Cancer.2024;[Epub] CrossRef
Endobronchial ultrasound bronchoscopy Franseen fine needle biopsy tool versus standard fine needle aspiration needle: Impact on diagnosis and tissue adequacy Matthew C. Aboudara, Timothy Saettele, Ossama Tawfik Respiratory Medicine.2023; 208: 107131. CrossRef
Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy Erin Faber, Horiana Grosu, Sharjeel Sabir, Francis Anthony San Lucas, Bedia A Barkoh, Roland L Bassett, Rajyalakshmi Luthra, John Stewart, Sinchita Roy-Chowdhuri Journal of Clinical Pathology.2022; 75(9): 612. CrossRef
Biomarker testing of cytology specimens in personalized medicine for lung cancer patients Hyojin Kim, Jin-Haeng Chung Journal of Pathology and Translational Medicine.2022; 56(6): 326. CrossRef
Formalin fixation for optimal concordance of programmed death‐ligand 1 immunostaining between cytologic and histologic specimens from patients with non–small cell lung cancer Bregje M. Koomen, Jose van der Starre‐Gaal, Judith M. Vonk, Jan H. von der Thüsen, Jacqueline J. C. van der Meij, Kim Monkhorst, Stefan M. Willems, Wim Timens, Nils A. ’t Hart Cancer Cytopathology.2021; 129(4): 304. CrossRef
Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies: Guidelines from the College of American Pathologists (CAP) Sinchita Roy-Chowdhuri Journal of Molecular Pathology.2021; 2(1): 23. CrossRef
A decade of change: Trends in the practice of cytopathology at a tertiary care cancer centre Peyman Dinarvand, Chinhua Liu, Sinchita Roy‐Chowdhuri Cytopathology.2021; 32(5): 604. CrossRef
False‐negative programmed death‐ligand 1 immunostaining in ethanol‐fixed endobronchial ultrasound‐guided transbronchial needle aspiration specimens of non‐small‐cell lung cancer patients Bregje M Koomen, Willem Vreuls, Mirthe de Boer, Emma J de Ruiter, Juergen Hoelters, Aryan Vink, Stefan M Willems Histopathology.2021; 79(4): 480. CrossRef
Influence of preanalytical variables on performance of delta-like protein 3 (DLL3) predictive immunohistochemistry Teodora Radonic, S. Duin, W. Vos, P. Kortman, Aeilko H. Zwinderman, Erik Thunnissen Virchows Archiv.2021; 478(2): 293. CrossRef
Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients Wei Wu, Ziyang Cao, Wei Zhang, Liping Zhang, Likun Hou, Chunyan Wu Diagnostic Pathology.2020;[Epub] CrossRef
Tumor cell representation by an improvised technique of fine-needle aspiration specimen acquisition and cell block preparation: Our experience in lung cancer cases in a peripheral center of eastern India AnupKr Boler, Shreosee Roy, Arghya Bandyopadhyay, Abhishek Bandyopadhyay, MrinalKanti Ghosh Journal of Cytology.2020; 37(2): 87. CrossRef
A new guideline from the College of American Pathologists to improve the adequacy of thoracic small specimens for ancillary studies Sinchita Roy‐Chowdhuri Cancer Cytopathology.2020; 128(10): 690. CrossRef
The utilization of cytologic and small biopsy samples for ancillary molecular testing Michael H. Roh Modern Pathology.2019; 32: 77. CrossRef
Diff-Quik Cytology Smears from Endobronchial Ultrasound Transbronchial Needle Aspiration Lymph Node Specimens as a Source of DNA for Next-Generation Sequencing Instead of Cell Blocks David Fielding, Andrew J. Dalley, Farzad Bashirzadeh, Mahendra Singh, Lakshmy Nandakumar, Amy E. McCart Reed, Debra Black, Stephen Kazakoff, John V. Pearson, Katia Nones, Nicola Waddell, Sunil R. Lakhani, Peter T. Simpson Respiration.2019; 97(6): 525. CrossRef
Molecular testing on endobronchial ultrasound (EBUS) fine needle aspirates (FNA): Impact of triage Simon Sung, John P. Crapanzano, David DiBardino, David Swinarski, William A. Bulman, Anjali Saqi Diagnostic Cytopathology.2018; 46(2): 122. CrossRef
Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling Sinchita Roy-Chowdhuri, Meenakshi Mehrotra, Ana Maria Bolivar, Rashmi Kanagal-Shamanna, Bedia A. Barkoh, Brette Hannigan, Stephanie Zalles, Wenrui Ye, Dzifa Duose, Russell Broaddus, Gregg Staerkel, Ignacio Wistuba, L. Jeffrey Medeiros, Rajyalakshmi Luthra Modern Pathology.2018; 31(7): 1036. CrossRef
Fluorescence in situ hybridization analysis on cytologic smears: An accurate and efficient method in the diagnosis of melanotic Xp11 translocation renal cancer Alia Gupta, Mark Micale, Kurt D. Bernacki Diagnostic Cytopathology.2018; 46(9): 786. CrossRef
Comprehensive Validation of Cytology Specimens for Next-Generation Sequencing and Clinical Practice Experience Agnes Balla, Ken J. Hampel, Mukesh K. Sharma, Catherine E. Cottrell, Nikoletta Sidiropoulos The Journal of Molecular Diagnostics.2018; 20(6): 812. CrossRef
Advances in Molecular Testing Techniques in Cytologic Specimens Sinchita Roy-Chowdhuri Surgical Pathology Clinics.2018; 11(3): 669. CrossRef
Next-generation molecular diagnosis: single-cell sequencing from bench to bedside Wanjun Zhu, Xiao-Yan Zhang, Sadie L. Marjani, Jialing Zhang, Wengeng Zhang, Shixiu Wu, Xinghua Pan Cellular and Molecular Life Sciences.2017; 74(5): 869. CrossRef
Big data from small samples: Informatics of next‐generation sequencing in cytopathology Sinchita Roy‐Chowdhuri, Somak Roy, Sara E. Monaco, Mark J. Routbort, Liron Pantanowitz Cancer Cytopathology.2017; 125(4): 236. CrossRef
Next‐generation sequencing of liquid‐based cytology non–small cell lung cancer samples Jordan P. Reynolds, Yaolin Zhou, Maureen A. Jakubowski, Zhen Wang, Jennifer A. Brainard, Roger D. Klein, Carol F. Farver, Francisco A. Almeida, Yu‐Wei Cheng Cancer Cytopathology.2017; 125(3): 178. CrossRef
Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies Sinchita Roy-Chowdhuri, Hui Chen, Rajesh R Singh, Savitri Krishnamurthy, Keyur P Patel, Mark J Routbort, Jawad Manekia, Bedia A Barkoh, Hui Yao, Sharjeel Sabir, Russell R Broaddus, L Jeffrey Medeiros, Gregg Staerkel, John Stewart, Rajyalakshmi Luthra Modern Pathology.2017; 30(4): 499. CrossRef
Diagnosis of anaplastic lymphoma kinase rearrangement in cytological samples through a fluorescence in situ hybridization–based assay: Cytological smears versus cell blocks Federica Zito Marino, Giulio Rossi, Matteo Brunelli, Maria Gabriella Malzone, Giuseppina Liguori, Giuseppe Bogina, Alessandro Morabito, Gaetano Rocco, Renato Franco, Gerardo Botti Cancer Cytopathology.2017; 125(5): 303. CrossRef
Next‐generation sequencing of cytologic preparations: An analysis of quality metrics David H. Hwang, Elizabeth P. Garcia, Matthew D. Ducar, Edmund S. Cibas, Lynette M. Sholl Cancer Cytopathology.2017; 125(10): 786. CrossRef
Recent advances in the pathology and molecular genetics of lung cancer: A practical review for cytopathologists Erika F. Rodriguez, Sara E. Monaco Journal of the American Society of Cytopathology.2016; 5(5): 252. CrossRef
Utilization of ancillary studies in the cytologic diagnosis of respiratory lesions: The papanicolaou society of cytopathology consensus recommendations for respiratory cytology Lester J. Layfield, Sinchita Roy‐Chowdhuri, Zubair Baloch, Hormoz Ehya, Kim Geisinger, Susan J. Hsiao, Oscar Lin, Neal I. Lindeman, Michael Roh, Fernando Schmitt, Nikoletta Sidiropoulos, Paul A. VanderLaan Diagnostic Cytopathology.2016; 44(12): 1000. CrossRef
Inflammatory myofibroblastic tumour Michael McDermott Seminars in Diagnostic Pathology.2016; 33(6): 358. CrossRef
Preanalytic Variables in Cytology: Lessons Learned From Next-Generation Sequencing—The MD Anderson Experience Sinchita Roy-Chowdhuri, John Stewart Archives of Pathology & Laboratory Medicine.2016; 140(11): 1191. CrossRef
Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society Sinchita Roy-Chowdhuri, Dara L. Aisner, Timothy Craig Allen, Mary Beth Beasley, Alain Borczuk, Philip T. Cagle, Vera Capelozzi, Sanja Dacic, Gilda da Cunha Santos, Lida P. Hariri, Keith M. Kerr, Sylvie Lantuejoul, Mari Mino-Kenudson, Andre Moreira, Kirtee Archives of Pathology & Laboratory Medicine.2016; 140(11): 1267. CrossRef
Identification of a novel partner gene, KIAA1217, fused to RET: Functional characterization and inhibitor sensitivity of two isoforms in lung adenocarcinoma Mi-Sook Lee, Ryong Nam Kim, Hoseok I, Doo-Yi Oh, Ji-Young Song, Ka-Won Noh, Yu-Jin Kim, Jung Wook Yang, Maruja E. Lira, Chang Hun Lee, Min Ki Lee, Yeoung Dae Kim, Mao Mao, Joungho Han, Jhingook Kim, Yoon-La Choi Oncotarget.2016; 7(24): 36101. CrossRef